Advanced expression options for your evolving needsDeveloping drugs that depend on a mammalian or microbial process poses unique challenges. The challenge increases when you need to move to cGMP to scale and commercialize new products. To accelerate production, developers need efficient and regulatory-compliant expression systems that scale quickly and reproducibly to meet future needs. With our portfolio of mammalian and microbial expression platforms and expertise, we can help you develop robust processes to equip you for ultimate commercial success.